News

‘Fitbit gets FDA approval for AFib detecting algorithm’ -TechCrunch Report

'https://techcrunch.com/2022/04/11/fitbit-gets-fda-approval-for-afib-detecting-algorithm/?tpcc=tcplustwitter

byBenzinga Newsdesk

April 11, 2022

1 minute read

‘https://techcrunch.com/2022/04/11/fitbit-gets-fda-approval-for-afib-detecting-algorithm/?tpcc=tcplustwitter

Tesla, Apple, Ford, Gitlab And EHang: Why These 5 Stocks Are Drawing Investors’ Attention Today

By Bhavik Nair

Today, 12:49 PM

Major Wall Street indices fell over 1% on Monday after stronger-than-expected November ISM services data led to speculation the Federal Reserve will continue on its rate hike path, increasing the chances of recession.

AAPL

Sesen Bio: Q4 Earnings Insights

By Benzinga Insights

Today, 12:49 PM

Sesen Bio (NASDAQ:SESN) reported its Q4 earnings results on Monday, February 28, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

SESN

Wedbush Maintains Outperform on NICE, Raises Price Target to $250

By Benzinga Newsdesk

Today, 12:49 PM

Wedbush analyst Daniel Ives maintains NICE (NASDAQ:NICE) with a Outperform and raises the price target from $220 to $250.

NICE

Fear & Greed Index Moves To ‘Neutral’ Zone Ahead Of Inflation Data

By Lisa Levin

Today, 12:49 PM

The CNN Money Fear and Greed index moved to the "Neutral" zone after US stocks closed sharply lower on Wednesday as midterm election results provided no clarity about the control of US Congress. Stocks settled lower after recording gains for three sessions in a row as the price of Bitcoin fell to a new bear market low level.

‘Fitbit gets FDA approval for AFib detecting algorithm’ -TechCrunch Report

Related Posts

Tesla, Apple, Ford, Gitlab And EHang: Why These 5 Stocks Are Drawing Investors’ Attention Today

Sesen Bio: Q4 Earnings Insights

Wedbush Maintains Outperform on NICE, Raises Price Target to $250

Fear & Greed Index Moves To ‘Neutral’ Zone Ahead Of Inflation Data